ES512897A0 - Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos. - Google Patents

Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos.

Info

Publication number
ES512897A0
ES512897A0 ES512897A ES512897A ES512897A0 ES 512897 A0 ES512897 A0 ES 512897A0 ES 512897 A ES512897 A ES 512897A ES 512897 A ES512897 A ES 512897A ES 512897 A0 ES512897 A0 ES 512897A0
Authority
ES
Spain
Prior art keywords
mammals
procedure
treatment
intestinal diseases
obtaining compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES512897A
Other languages
English (en)
Other versions
ES8304539A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES512897A0 publication Critical patent/ES512897A0/es
Publication of ES8304539A1 publication Critical patent/ES8304539A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES512897A 1981-06-08 1982-06-07 Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos. Expired ES8304539A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/271,748 US4374932A (en) 1981-06-08 1981-06-08 5-ASA Drug delivery system

Publications (2)

Publication Number Publication Date
ES512897A0 true ES512897A0 (es) 1983-03-01
ES8304539A1 ES8304539A1 (es) 1983-03-01

Family

ID=23036907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512897A Expired ES8304539A1 (es) 1981-06-08 1982-06-07 Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos.

Country Status (13)

Country Link
US (1) US4374932A (es)
EP (1) EP0066861B1 (es)
JP (1) JPS57212119A (es)
AU (1) AU8462282A (es)
CA (1) CA1200204A (es)
DE (1) DE3262768D1 (es)
DK (1) DK253782A (es)
ES (1) ES8304539A1 (es)
IE (1) IE53518B1 (es)
NO (1) NO153396C (es)
NZ (1) NZ200882A (es)
PT (1) PT75021B (es)
ZA (1) ZA823980B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (es) * 1980-03-20 1982-03-11
SE8405924L (sv) * 1984-11-23 1986-05-24 Pharmacia Ab Nya azoforeningar
EP0611306B1 (en) * 1991-11-08 1998-07-08 Somatogen, Inc. Hemoglobins as drug delivery agents
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
TWI249519B (en) 2000-08-29 2006-02-21 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
EP1429728A1 (en) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Sustained release preparations
US7825106B2 (en) 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US7737133B2 (en) * 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
EP1773767B1 (en) 2004-07-07 2016-03-09 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
FR2986010A1 (fr) * 2012-01-19 2013-07-26 Biomerieux Sa Detection in vitro de microorganismes presentant une activite azoreductase
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
CN108479727A (zh) * 2018-03-20 2018-09-04 中山大学惠州研究院 一种水杨酸改性的苯乙烯聚合物及其吸附回收工业废水中苯胺类组分的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB408676A (en) * 1931-10-17 1934-04-16 Ig Farbenindustrie Ag The manufacture of symmetrically substituted azobenzene compounds
US2697059A (en) * 1951-01-22 1954-12-14 Edwin L Gustus Hydroxy aromatic carboxylate-resin adsorption composition
US2721827A (en) * 1952-08-29 1955-10-25 Edwin L Gustus Composition containing polyamine resin having adsorbed thereon an anion of para-aminosalicylic acid
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US3143465A (en) * 1961-06-19 1964-08-04 Wallace & Tiernan Inc Pharmaceutical preparations comprising phosphorus containing cation exchange resins having a basic drug adsorbed thereon; and treatment therewith
SE7905051L (sv) * 1979-06-11 1980-12-12 Pharmacia Ab Nya sulfonamider
SE8002322L (sv) * 1980-03-26 1981-09-27 Pharmacia Ab Medel for behandling av inflammatoriska tarmsjukdomar
DE3027013A1 (de) * 1980-07-17 1982-02-18 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln

Also Published As

Publication number Publication date
ZA823980B (en) 1983-07-27
PT75021B (en) 1984-01-04
NZ200882A (en) 1985-08-30
NO821898L (no) 1982-12-09
PT75021A (en) 1982-07-01
DE3262768D1 (de) 1985-05-02
CA1200204A (en) 1986-02-04
US4374932A (en) 1983-02-22
NO153396B (no) 1985-12-02
ES8304539A1 (es) 1983-03-01
JPS57212119A (en) 1982-12-27
AU8462282A (en) 1982-12-16
NO153396C (no) 1986-03-12
IE821361L (en) 1982-12-08
EP0066861A1 (en) 1982-12-15
EP0066861B1 (en) 1985-03-27
IE53518B1 (en) 1988-12-07
DK253782A (da) 1982-12-09

Similar Documents

Publication Publication Date Title
ES512897A0 (es) Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos.
ES511776A0 (es) Procedimiento para el tratamiento de corrientes continuas de aguas residuales.
MX5222E (es) Procedimiento para el tratamiento de lactosuero
IT8048131A0 (it) Procedimento per la eliminazione di bifenil policlorurati
ES516368A0 (es) Procedimiento para la obtencion de fenoxifenil-azol-metilcetonas y-carbinoles.
NO166494C (no) Fremgangsmaate for fremstilling av human lymfoblastoid interferon.
ES515051A0 (es) Procedimiento para el tratamiento de aguas.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
ES513386A0 (es) Procedimiento de obtencion de composiciones oftalmologicas.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
IT8119673A0 (it) Composizioni farmaceutiche per il trattamento di osteopatie.
AR230367A1 (es) Proceso para el tratamiento de tabaco
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
AR228396A1 (es) Metodo para la preparacion de composiciones farmaceuticas para el tratamiento de la piel
ES513387A0 (es) Procedimiento de obtencion de composiciones oftalmologicas.
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT8267794A0 (it) Composizione per trattamento del glaucoma
ES511577A0 (es) Procedimiento para la preparacion del heteropolisacarido s-198.
IT8020873A0 (it) Procedimento per la preparazione di solfossidi di penicellina.
IT8319024A0 (it) Composizione medicinale per il trattamento di certe neurovirosi.
ES521088A0 (es) Procedimiento para la preparacion de pirroles triciclicos.
ES512448A0 (es) Procedimiento para el tratamiento de una escoria fosfurada.
AR229608A1 (es) Aparato para el tratamiento de hojas de vidrio
ES517888A0 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.
IT7920415A0 (it) Preparazione di ceruletide. procedimento per la